The law of diminishing returns applies, and expectations should adjust accordingly with each subsequent cycle
The peptide remains available through research chemical suppliers, though the quality, purity, and reliability of these sources varies enormously
[4] [5] It has been encountered as a designer drug mainly in racehorses, [6] but is also prohibited for use by athletes in competition by the World Anti-Doping Agency, and is classified as a prescription medicine in some jurisdictions such as Australia and New Zealand
Pentadeca arginate (PDA) and BPC-157 should not be used by anyone outside an IRB-approved clinical research study
"Thymosin Beta 4 Clinical Development Program." Phase II Data, 2010
Compounds like BPC-157 and TB-500 support tissue repair through different mechanisms than 5-amino-1mq